Related Experiment Video
Updated: Jul 14, 2026

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
Repression of E1AF transcriptional activity by sumoylation and PIASy
Tamotsu Nishida1, Motoko Terashima, Kiyoko Fukami
1Department of Human Functional Genomics, Life Science Research Center, Mie University, 1577 Kurima-machiya, Tsu 514-8507, Japan. nishida@gene.mie-u.ac.jp
Abstract:
E1AF is a member of the Ets transcriptional factor family, and it plays a crucial role in tumor metastasis. However, the molecular mechanisms regulating its activity are not well characterized. In this study, we show that E1AF is sumoylated at four lysine residues, both in vivo and in vitro. Replacement of these lysines by arginine enhanced the transcriptional activity of E1AF, suggesting that sumoylation negatively regulates E1AF activity. We further demonstrated that PIASy enhanced sumoylation of E1AF as a specific SUMO-E3 ligase. In addition, PIASy repressed the transcriptional activity of both the wild-type and sumoylation defective mutants. However, the C342A mutant of PIASy, which abrogates SUMO-E3 ligase activity, had a significantly decreased ability to repress E1AF activity. Taken together, our results indicate that PIASy negatively regulates E1AF-mediated transcription by both E1AF sumoylation in a dependent and independent fashion.
Insights
Ets transcription factor E1AF
Area of Science:
- Molecular biology
- Cancer research
- Transcriptional regulation
Background:
- Ets transcription factor E1AF is implicated in tumor metastasis.
- Mechanisms controlling E1AF activity remain largely unknown.
Purpose of the Study:
- To investigate the role of sumoylation and PIASy in regulating E1AF transcriptional activity.
Main Methods:
- In vivo and in vitro sumoylation assays.
- Site-directed mutagenesis of E1AF and PIASy.
- Transcriptional activity assays.
Main Results:
- E1AF undergoes sumoylation at four lysine residues, which negatively regulates its activity.
- PIASy acts as a SUMO-E3 ligase, enhancing E1AF sumoylation.
- PIASy represses E1AF activity via both sumoylation-dependent and -independent mechanisms.
Conclusions:
- PIASy negatively regulates E1AF-mediated transcription through dual mechanisms.
- Sumoylation is a key post-translational modification controlling E1AF function in cancer progression.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
RNA Polymerase II Accessory Proteins
Co-activators and Co-repressors
Abnormal Proliferation
The JAK-STAT Signaling Pathway
Regulation of Expression at Multiple Steps

